Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Short Squeezes -- Ignore unavailable to you. Want to Upgrade?

To: SR. who wrote (1)	10/9/1997 10:37:00 AM
From: keith schaefer	Respond to of 21

Dear SR: Short position can be got on Stockwatch, but you might have to pay for them. My real time quotes on stockwatch cost $45/month for VSE and ASE. Born & raised an Ontarian, but came to God's country 9 years ago. And hey, we have our own A-hole premier out here, got himself magically elected by the most brazen misrepresentation of budget tricks - said he had a $300 million surplus when it was really a $500 million deficit.

To: SR. who wrote (1)	2/28/1998 1:45:00 AM
From: Bruce Cullen	Respond to of 21

This is a majot squeeze 16 mil float 7 mil short+ Look at this closely! Chartand what it did at close today then look at this all...... Post from yahoo Re (ORG) great info look at these specs--->http://www.organogenesis.com/docs97/framtech.htm New Cell Technologies In early 1996, Organogenesis formed a New Cell Technologies group focused on applying the Company's experience with difficult-to-culture cells to the development of medical products for conditions considered best treated with living cells. This group leverages the Company's proven expertise in procuring, culturing, optimizing and cryopreserving mammalian cells.